NHS England has unveiled new processes designed to fast track clinical trials undertaken across the NHS, and boost access for patients.
On Monday Takeda Pharmaceutical confirmed to acquire Shire for £45.3 billion ($61.50 billion). The final deal will be 46 percent cash and 54 percent stock.
San Francisco-based appointment booking application Solv Health announced that it has raised $16.8 million in Series B funding from Greylock Partners, along with Benchmark and Aspect Ventures. The company also unveiled its new Solv Pay feature, which helps to make payment quicker and easier for its users.
Mayo Clinic researchers found success with an mHealth app - EpiFinder, which can diagnose Epilepsy (A disruption in which nerve cell activity in the brain is disturbed, causing seizures). During recent research conducted at Mayo Clinic, the Epifinder app recognized epilepsy in almost 87percent of the cases.
Merck generated more than $1.5 billion in first-quarter vaccine sales. (Merck)
US regulators are undertaking a priority review of Roche unit Genentech’s PD-L1 inhibitor Tecentriq, in combination with Avastin and standard chemotherapy for some patients with lung cancer.
Today, Digital behavioral health company, Lyra Health announced that it has raised $45 million in Series B funding in a new financing round including Tenaya Capital, Glynn Capital, Crown Ventures, and Casdin Capital, as well as returning funders Greylock Partners, Venrock, and Providence Ventures.
Consumers are depending on mHealth applications and wearable devices to improve their medication abidance.
A Fitbit official disclosed eight mobile health apps, including two focused on diabetes management and one on oncology care.
During the Fitbit Q1 earnings call, the company confirmed its focus on digital health regardless of the expected decline in sales numbers. Currently, Fitbit is focusing on its new alliance with Google, wherein the two companies will work together to speed up innovation in the digital health space to provide clear EHRs and precise patient data to help the clinicians.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.